High-capacity poly(2-oxazoline) formulation of TLR 7/8 agonist extends survival in a chemo-insensitive, metastatic model of lung adenocarcinoma

Natasha Vinod, Duhyeong Hwang, Salma H. Azam, Amanda E.D. Van Swearingen, Elizabeth Wayne, Sloane Christian Fussell, Marina Sokolsky‐Papkov, Chad V. Pecot, Alexander V. Kabanov

Science Advances · 2020 · 64 citations · 36 references

DOIFull text

Open access

Concepts

Abstract

immune response. Our study demonstrates the promise of poly(2-oxazoline)-formulated Resiquimod for treating metastatic NSCLC.

References

36